References
- Ahmad N, Alam MK, Shehbaz A, Khan A, Mannan A, Hakim SR, Bight D, Wais M (2005): Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis. J Drug Target 13: 555–561.
- Aligiannis N, Kalpoutzakis E, Mitaka S, Chinou IB (2001): Composition and antimicrobial activity of the essential oils of two Origanum species. J Agric Food Chem 49: 4168–4170.
- Boskey ER, Cone RA, Whaley KJ, Moench TR (2001): Origins of vaginal acidity: High d/l lactate ratio is consistent with bacteria being the primary source. Hum Reprod 16: 1809–1813.
- Cal K (2006): How does the type of vehicle influence the in vitro skin absorption and elimination kinetics of terpenes? Arch Dermatol Res 297: 311–315.
- Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT, Kim CK (2002): Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release 82: 39–50.
- Cunha AP, Silva AP, Roque OR (2003). Plantas e Produtos Vegetais em Fitoterapia. Lisbon, Fundação Calouste Gulbenkian, pp. 606–607.
- das Neves J, Bahia MF (2006): Gels as vaginal drug delivery systems. Int J Pharm 318: 1–14.
- das Neves J, Amaral MH, Bahia MF (2007): Mechanical properties of a vaginal gel containing Thymus vulgaris essential oil (1% w/w), Third Pharmaceutical Sciences World Congress, Amsterdam, The Netherlands, Abstract DD-M-089.
- das Neves J, Amaral MH, Bahia MF (2008): Vaginal drug delivery. In: ed. Gad SC, Pharmaceutical Manufacturing Handbook: Production and Processes, Hoboken, NJ, Wiley, pp. 809–878.
- Duarte MC, Figueira GM, Sartoratto A, Reader VL, Delarmelina C (2005): Anti-Candida activity of Brazilian medicinal plants. J Ethnopharmacol 97: 305–311.
- Maccioni AM, Anchisi C, Sanna A, Sardu C, Dessì S (2002): Preservative systems containing essential oils in cosmetic products. Int J Cosmet Sci 24: 53–59.
- NCCLS (National Committee for Clinical Laboratory Standards) (2002): Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A2. Wayne, PA, CLSI.
- Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE (2004): Guidelines for treatment of candidiasis. Clin Infect Dis 38: 161–189.
- Pauli A (2006): Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med Res Rev 26: 223–268.
- Pina-Vaz C, Gonçalves Rodrigues A, Pinto E, Costa-de-Oliveira S, Tavares C, Salgueiro L, Cavaleiro C, Gonçalves MJ, Martinez-de-Oliveira J (2004): Antifungal activity of Thymus oils and their major compounds. J Eur Acad Dermatol Venereol 18: 73–78.
- Robinson JR, Bologna WJ (1994): Vaginal and reproductive system treatments using a bioadhesive polymer. J Control Release 28: 87–94.
- Sobel JD (2007): Vulvovaginal candidosis. Lancet 369: 1961–1971.
- Spinillo A, Capuzzo E, Gulminetti R, Marone P, Colonna L, Piazzi G (1997): Prevalence of and risk factors for fungal vaginitis caused by non-albicans species. Am J Obstet Gynecol 176: 138–141.
- Thorgeirsdottir TO, Thormar H, Kristmundsdottir T (2005): The influence of formulation variables on stability and microbicidal activity of monoglyceride monocaprin. J Drug Del Sci Tech 15: 233–236.